Combinedin vitro modulation of adriamycin resistance

This publication has 16 references indexed in Scilit:

• The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin
  Cancer Treatment Reviews, 1990
• Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity ofcis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline
  Cancer Chemotherapy and Pharmacology, 1990
• Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells
  European Journal of Cancer and Clinical Oncology, 1990
• Isolation by flow cytometry of a human ovarian tumor cell subpopulation exhibiting a high glutathione content phenotype and increased resistance to adriamycin
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1989
• Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
  Journal of Clinical Oncology, 1989
• Expression of Multidrug Resistance Gene in Human Cancers
  JNCI Journal of the National Cancer Institute, 1989
• Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug Resistance
  Science, 1988
• Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
  Nature, 1985
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985